Iovance Biotherapeutics
IOVAIovance Biotherapeutics is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Iovance Biotherapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 6/5/2025 | Buy | Kirby, Daniel Gordon | Chief Commercial Officer | $1.8 | $55,200 |
| 5/23/2025 | Buy | Puri, Raj K. | Chief Regulatory Officer | $1.7 | $9,743 |
| 5/14/2025 | Buy | Vogt, Frederick G. | Interim CEO & General Counsel | $1.7 | $42,250 |
| 11/12/2024 | Sell | Maynard, Ryan D. | Director | $10.1 | $503,000 |
| 2/20/2024 | Buy | Rothbaum, Wayne P. | Director | $9.2 | $45,750,000 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)